Evidence map›Paper›PMID 36292449›Full record

ArticleHealthcare (Basel, Switzerland)2022

Cervical Cancer Diagnosis Using an Integrated System of Principal Component Analysis, Genetic Algorithm, and Multilayer Perceptron.

Odai Y Dweekat, Sarah S Lam

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Odai Y DweekatDepartment of Systems Science and Industrial Engineering, Binghamton University, Binghamton, NY 13902, USA.ORCID 0000-0001-8710-2306
Sarah S LamDepartment of Systems Science and Industrial Engineering, Binghamton University, Binghamton, NY 13902, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer is one of the most dangerous diseases that affect women worldwide. The diagnosis of cervical cancer is challenging, costly, and time-consuming. Existing literature has focused on traditional machine learning techniques and deep learning to identify and predict cervical cancer. This research proposes an integrated system of Genetic Algorithm (GA), Multilayer Perceptron (MLP), and Principal Component Analysis (PCA) that accurately predicts cervical cancer. GA is used to optimize the MLP hyperparameters, and the MLPs act as simulators within the GA to provide the prediction accuracy of the solutions. The proposed method uses PCA to transform the available factors; the transformed features are subsequently used as inputs to the MLP for model training. To contrast with the PCA method, different subsets of the original factors are selected. The performance of the integrated system of PCA-GA-MLP is compared with nine different classification algorithms. The results indicate that the proposed method outperforms the studied classification algorithms. The PCA-GA-MLP model achieves the best accuracy in diagnosing Hinselmann, Biopsy, and Cytology when compared to existing approaches in the literature that were implemented on the same dataset. This study introduces a robust tool that allows medical teams to predict cervical cancer in its early stage.

Indexed as

cervical cancergenetic algorithmmachine learningmultilayer perceptronprincipal component analysis

Identifiers

PMID36292449
PMCPMC9601935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.